biotech · Type 1 Diabetes · Coronavirus · SABS
SAB Biotherapeutics
SAB Biotherapeutics is a biotech organization headquartered in Gaithersburg, USA. It trades on NYSE under ticker SABS. Primary therapeutic focus areas include Type 1 Diabetes, Coronavirus, Influenza A H1N1, Influenza Typ
Gaithersburg, USA HQ
2016 Founded
39 Employees
Public company Type
SABS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 2016
- Employees
- 39
- Programs
- 8
- Drugs
- 10
- Patents
- 1
SAB-176
Phase 2 · mab · Influenza A H1N1
SAB-176 for Influenza A H1N1 is a Phase 2 program (mab) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Internal code SAB-176-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- SAB Biotherapeutics
- Phase
- Phase 2
- Modality
- mab
- Indication
- Influenza A H1N1
- Status
- completed
- Trials
- 1